Clinical Trials for Naveris

Explore 4 clinical trials worldwide

Showing 1-4 of 4 trials

Active filters:Status: Recruiting, Active, not recruiting, Enrolling by invitation, Not yet recruitingSponsor: Naveris

Clinical Trials (4)

A Study of HB-202/HB-201 in People With Human Papilloma Virus 16-Positive Head and Neck Squamous Cell Cancer (HPV 16+ HNSCC)

EARLY_PHASE1Recruiting

10 participants

Started: Apr 15, 2024 · Completed: Apr 30, 2027

1 condition3 sponsors7 locations

Circulating Human Papilloma Virus (HPV) DNA for the Screening and Surveillance of Gynecologic Cancers

100 participants

Started: Aug 10, 2022 · Completed: Aug 10, 2026

2 conditions2 sponsors1 location

Risk Adapted De-Intensification of Radio-Chemotherapy for Oropharyngeal Squamous Cell Carcinoma

PHASE2Recruiting

250 participants

Started: May 16, 2022 · Completed: Jun 30, 2032

1 condition2 sponsors3 locations

Risk-adapted Therapy in HPV+ Oropharyngeal Cancer Using Circulating Tumor (ct)HPV DNA Profile - The ReACT Study

PHASE2Recruiting

145 participants

Started: Jul 2, 2021 · Completed: Jun 1, 2032

12 conditions2 sponsors2 locations